These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15089783)

  • 21. Preventing type 2 diabetes using combination therapy: design and methods of the CAnadian Normoglycaemia Outcomes Evaluation (CANOE) trial.
    Zinman B; Harris SB; Gerstein HC; Young TK; Raboud JM; Neuman J; Hanley AJ
    Diabetes Obes Metab; 2006 Sep; 8(5):531-7. PubMed ID: 16918588
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preservation of β-cell function: the key to diabetes prevention.
    DeFronzo RA; Abdul-Ghani MA
    J Clin Endocrinol Metab; 2011 Aug; 96(8):2354-66. PubMed ID: 21697254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic prevention or delay of type 2 diabetes mellitus.
    Anderson DC
    Ann Pharmacother; 2005 Jan; 39(1):102-9. PubMed ID: 15562143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Prevention of type 2 diabetes: lifestyle changes or pharmacological interventions?].
    Scheen AJ; Letiexhe MR; Ernest P
    Rev Med Liege; 2003 Apr; 58(4):206-10. PubMed ID: 12868322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What's preventing us from preventing type 2 diabetes?
    Fradkin JE; Roberts BT; Rodgers GP
    N Engl J Med; 2012 Sep; 367(13):1177-9. PubMed ID: 23013070
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevention of type 2 diabetes mellitus: is it feasible?
    Palermo A; Maggi D; Maurizi AR; Pozzilli P; Buzzetti R
    Diabetes Metab Res Rev; 2014 Mar; 30 Suppl 1():4-12. PubMed ID: 24353270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
    Tomlinson J; Millward A; Stenhouse E; Pinkney J
    Diabet Med; 2010 May; 27(5):498-515. PubMed ID: 20536945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preventing Type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view.
    Zimmet P; Shaw J; Alberti KG
    Diabet Med; 2003 Sep; 20(9):693-702. PubMed ID: 12925046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomised controlled trial evaluating lifestyle interventions in people with impaired glucose tolerance.
    Oldroyd JC; Unwin NC; White M; Mathers JC; Alberti KG
    Diabetes Res Clin Pract; 2006 May; 72(2):117-27. PubMed ID: 16297488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.
    Chiasson JL; Josse RG; Gomis R; Hanefeld M; Karasik A; Laakso M;
    Lancet; 2002 Jun; 359(9323):2072-7. PubMed ID: 12086760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention of type 2 diabetes: are we ready?
    Bouche C; Goldfine AB
    Minerva Med; 2003 Feb; 94(1):9-18. PubMed ID: 12719698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential for lifestyle change to influence the progression of impaired glucose tolerance to non-insulin-dependent diabetes mellitus.
    Bourn DM
    Diabet Med; 1996 Nov; 13(11):938-45. PubMed ID: 8946151
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevention of type 2 diabetes mellitus: recent advances.
    Younis N; Soran H; Farook S
    QJM; 2004 Jul; 97(7):451-5. PubMed ID: 15208433
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of new-onset diabetes and impaired fasting glucose in patients with recent myocardial infarction and the effect of clinical and lifestyle risk factors.
    Mozaffarian D; Marfisi R; Levantesi G; Silletta MG; Tavazzi L; Tognoni G; Valagussa F; Marchioli R
    Lancet; 2007 Aug; 370(9588):667-75. PubMed ID: 17720018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Type 2 diabetes mellitus: practical approaches for primary care physicians.
    Gavin JR; Freeman JS; Shubrook JH; Lavernia F
    J Am Osteopath Assoc; 2011 May; 111(5 Suppl 4):S3-12; quiz S13. PubMed ID: 21697547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impaired glucose tolerance and impaired fasting glucose.
    Rao SS; Disraeli P; McGregor T
    Am Fam Physician; 2004 Apr; 69(8):1961-8. PubMed ID: 15117017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategies to prevent type 2 diabetes.
    Abuissa H; Bel DS; O'keefe JH
    Curr Med Res Opin; 2005 Jul; 21(7):1107-14. PubMed ID: 16004680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prevention by life style intervention and medication. To run away from type 2 diabetes].
    Wepner U
    MMW Fortschr Med; 2004 Apr; 146(14):16. PubMed ID: 15344745
    [No Abstract]   [Full Text] [Related]  

  • 39. Preventing type 2 diabetes in high risk patients: an overview of lifestyle and pharmacological measures.
    Liberopoulos EN; Tsouli S; Mikhailidis DP; Elisaf MS
    Curr Drug Targets; 2006 Feb; 7(2):211-28. PubMed ID: 16475962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevention of type 2 diabetes--lifestyle change or pharmacotherapy? A challenge for the 21st century.
    Simpson RW; Shaw JE; Zimmet PZ
    Diabetes Res Clin Pract; 2003 Mar; 59(3):165-80. PubMed ID: 12590013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.